Media & Press

The story & the science behind it.

Interviews with our founder and clinical voices, plus the resources journalists, investors, and partners need — ready to download.

Podcasts & Interviews

Hear it in their own words.

Conversations on immune modulation, neuroinflammation, and the path to first-in-human ALS trials.

Fully Alive · with Zach Gurick cover art
Fully Alive · with Zach Gurick

Healing Neurodegenerative Diseases In A Different Way With Dr. Ron Lane

Dr. Ron Lane joins Fully Alive to discuss Hope Neuron's first-of-its-kind immune reset approach for neurodegenerative diseases including ALS, Alzheimer's, and Parkinson's.

The conversation explores the personal story behind the work, the role of immune dysfunction in neurodegeneration, and how a device-based platform may open a different path for treating diseases often seen as unstoppable.

Start listening
Empowered Patient Podcast · with Karen Jagoda cover art
Empowered Patient Podcast · with Karen Jagoda

Immune Modulation Therapy for ALS with Dr. Ronald Lane

Dr. Ronald Lane outlines Hope Neuron's non-stem cell Immune Modulation Therapy approach for Amyotrophic Lateral Sclerosis (ALS), focusing on the scientific rationale for targeting neuroinflammation and the broader therapeutic implications for patients facing this devastating disease.

The conversation highlights the role of immune dysregulation in ALS progression and the importance of advancing evidence-based strategies designed to meaningfully impact outcomes — a discussion that lands at a moment of growing public awareness of ALS.

Start listening
BiohackerBlondie Podcast cover art
BiohackerBlondie Podcast

Rewriting Neurodegeneration: How Hope Neuron Therapeutx Resets the Immune System

A deep dive into the SELtx™ platform — how a closed-loop, non-drug immune reset is being developed to change the trajectory of ALS and other neurodegenerative disease.

Start listening
Press Kit

Downloadable resources.

Official documents for media, investors, and partners. Resources open in a new tab.

For Press & Partners

Connect with our communications team.

Get in touch